RU2513852C1 - UNIFORMLY TRITIUM-LABELLED PYRO-Glu-His-Pro-NH2 - Google Patents
UNIFORMLY TRITIUM-LABELLED PYRO-Glu-His-Pro-NH2 Download PDFInfo
- Publication number
- RU2513852C1 RU2513852C1 RU2013105643/04A RU2013105643A RU2513852C1 RU 2513852 C1 RU2513852 C1 RU 2513852C1 RU 2013105643/04 A RU2013105643/04 A RU 2013105643/04A RU 2013105643 A RU2013105643 A RU 2013105643A RU 2513852 C1 RU2513852 C1 RU 2513852C1
- Authority
- RU
- Russia
- Prior art keywords
- pyro
- glu
- pro
- tritium
- uniformly
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Изобретение относится к области органической химии и может найти применение в аналитической химии и биологических исследованиях.The invention relates to the field of organic chemistry and may find application in analytical chemistry and biological research.
При изучении физиологически активных соединений необходимы их меченые аналоги.When studying physiologically active compounds, their labeled analogues are necessary.
Известно, что замена атомов соединений на их меченые аналоги не приводит к изменению каких-либо свойств исходного соединения (Evans Е.А. - Tritium and its compounds London Butterworths, 1974, p.48) [1].It is known that replacing the atoms of compounds with their labeled analogues does not lead to a change in any properties of the starting compound (Evans EA - Tritium and its compounds London Butterworths, 1974, p. 48) [1].
Известен пиро-Glu-His-Pro-NH2 формулы:Known pyro-Glu-His-Pro-NH 2 formula:
пиро-Glu-His-Pro-NH2 - пептидный гормон гипоталамуса (Е.А. Nillni, К.А. Sevarino. // Endocrine Reviews, 1999, V. 20, No 5, P.599-648 [2]; R.O'Leary, B.O'Connor. // J. Neurochem., 1995, V. 65, P.953-963 [3]; N. Shibusawa, K. Hashimoto, M. Yamada. // The Cerebellum, 2008, P.84-95 [4]; J. Boler, F. Enzmann, K. Folkers, C. Y. Bowers, A. V. Serially. //Biochem. Biophys. Res. Commun., 1969, V. 37, P. 705-710 [5]; V. Monga, C.L. Meena, N. Kaur, R. Jain. //Current Medicinal Chemistry, 2008, V. 15, P.2718-2733 [6]). Данный гормон является нейропептидом, он принимает участие в нормализации некоторых психических функций организма человека. Например, установлено наличие антидепрессивного действия экзогенного пиро-Glu-His-Pro-NH2 при депрессиях. Основная химико-биологическая функция данного гормона заключается в усилении производства пролактина и в большей степени - усилении производства тиреотропного гормона передней долей гипофиза.pyro-Glu-His-Pro-NH 2 is the peptide hormone of the hypothalamus (E.A. Nillni, K.A. Sevarino. // Endocrine Reviews, 1999, V. 20, No. 5, P.599-648 [2]; R. O'Leary, B. O'Connor. // J. Neurochem., 1995, V. 65, P.953-963 [3]; N. Shibusawa, K. Hashimoto, M. Yamada. // The Cerebellum 2008, P.84-95 [4]; J. Boler, F. Enzmann, K. Folkers, CY Bowers, AV Serially. // Biochem. Biophys. Res. Commun., 1969, V. 37, P. 705 -710 [5]; V. Monga, CL Meena, N. Kaur, R. Jain. // Current Medicinal Chemistry, 2008, V. 15, P.2718-2733 [6]). This hormone is a neuropeptide, it takes part in the normalization of certain mental functions of the human body. For example, the presence of the antidepressant action of exogenous pyro-Glu-His-Pro-NH 2 in depression was established. The main chemical and biological function of this hormone is to increase the production of prolactin and, to a greater extent, to increase the production of thyroid-stimulating hormone by the anterior pituitary gland.
Однако его равномерномеченный тритием аналог не описан.However, its counterpart uniformly labeled with tritium is not described.
Техническим результатом, достигаемым настоящим изобретением, является расширение ассортимента меченых аналогов физиологически активных соединений.The technical result achieved by the present invention is to expand the range of labeled analogues of physiologically active compounds.
Достигается указанный технический результат получением равномерномеченного тритием пиро-Glu-His-Pro-NH2 формулы I:This technical result is achieved by obtaining uniformly labeled with tritium pyro-Glu-His-Pro-NH 2 formula I:
Ниже приведен пример реализации изобретения.The following is an example implementation of the invention.
Пример IExample I
Раствором 5 мг пиро-Glu-His-Pro-NH2 в 75 мкл метанола пропитывали 150 мг окиси алюминия и лиофилизировали. Высушенный остаток механически перемешивали с 10 мг 5% Pd/Al2O3. В ампулу помещали 66 мг смеси, вакуумировали и заполняли газообразным тритием до давления 400 гПа. Реакцию вели при 200°C в течение 15 мин. Ампулу снова вакуумировали, катализатор наносили на фильтр, вещество экстрагировали метанолом (5×0.5 мл). Экстракты упаривали, остаток растворяли в метаноле (3×1 мл) и вновь упаривали для удаления лабильного трития. Конечный метанольный раствор содержал 180 мКи пептида.A solution of 5 mg of pyro-Glu-His-Pro-NH 2 in 75 μl of methanol was impregnated with 150 mg of aluminum oxide and lyophilized. The dried residue was mechanically mixed with 10 mg of 5% Pd / Al 2 O 3 . 66 mg of the mixture was placed in an ampoule, evacuated, and filled with gaseous tritium to a pressure of 400 hPa. The reaction was carried out at 200 ° C for 15 minutes. The ampoule was again evacuated, the catalyst was applied to the filter, the substance was extracted with methanol (5 × 0.5 ml). The extracts were evaporated, the residue was dissolved in methanol (3 × 1 ml) and again evaporated to remove labile tritium. The final methanol solution contained 180 mCi of peptide.
Анализ проводили на колонке Reprosil pur C18aq, 4*150 мм, 5 мкм, скорость потока - 1 мл/мин, А - вода с 0.1% гептафтормасляной кислотой, Б - метанол, градиент Б→0-30% за 15 мин: время удерживания пиро-Glu-His-Pro-NH2 - 11.54 мин. Равномерномеченный пиро-Glu-His-Pro-NH2 очищали препаративной высокоэффективной жидкостной хроматографией.The analysis was performed on a Reprosil pur C18aq column, 4 * 150 mm, 5 μm, flow rate - 1 ml / min, A - water with 0.1% heptafluorobutyric acid, B - methanol, gradient B → 0-30% for 15 min: retention time pyro-Glu-His-Pro-NH 2 - 11.54 min. Uniform pyro-Glu-His-Pro-NH 2 was purified by preparative high performance liquid chromatography.
Хроматографию проводили на колонке Kromasil 100C18, 8×150 мм, 7 мкм, система: А - вода с 0.1% гептафтормасляной кислотой, Б - метанол, градиент Б→0-50% за 30 мин, скорость потока - 2 мл/мин. В результате получен меченый пептид с 75% радиохимической чистотой (80 мКи).Chromatography was performed on a Kromasil 100C 18 , 8 × 150 mm, 7 μm column, system: A — water with 0.1% heptafluorobutyric acid, B — methanol, gradient B → 0-50% in 30 min, flow rate - 2 ml / min. As a result, a labeled peptide with 75% radiochemical purity (80 mCi) was obtained.
После повторной очистки радиохимическая чистота равномерномеченного пиро-Glu-His-Pro-NH2 - не менее 98%, выход - 15-20%, молярная радиоактивность - 75 Ки/ммоль.After repeated purification, the radiochemical purity of the uniformly labeled pyro-Glu-His-Pro-NH 2 is at least 98%, the yield is 15-20%, the molar radioactivity is 75 Ci / mmol.
Таким образом, получен равномерномеченный тритием пиро-Glu-His-Pro-NH2.Thus, pyro-Glu-His-Pro-NH 2 uniformly labeled with tritium was obtained.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013105643/04A RU2513852C1 (en) | 2013-02-11 | 2013-02-11 | UNIFORMLY TRITIUM-LABELLED PYRO-Glu-His-Pro-NH2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013105643/04A RU2513852C1 (en) | 2013-02-11 | 2013-02-11 | UNIFORMLY TRITIUM-LABELLED PYRO-Glu-His-Pro-NH2 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2513852C1 true RU2513852C1 (en) | 2014-04-20 |
Family
ID=50481113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013105643/04A RU2513852C1 (en) | 2013-02-11 | 2013-02-11 | UNIFORMLY TRITIUM-LABELLED PYRO-Glu-His-Pro-NH2 |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2513852C1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2624439C1 (en) * | 2016-05-17 | 2017-07-04 | Федеральное государственное бюджетное учреждение науки Институт молекулярной генетики Российской академии наук | 5-oxo-pro-arg-pro labeled by tritium on all amino acid residues |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4041023A (en) * | 1976-04-14 | 1977-08-09 | Hoffmann-La Roche Inc. | Labelled peptides |
SU1063390A1 (en) * | 1982-01-07 | 1983-12-30 | Всесоюзный онкологический научный центр АМН СССР | Method of diagnosis of thyroid gland cancer |
-
2013
- 2013-02-11 RU RU2013105643/04A patent/RU2513852C1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4041023A (en) * | 1976-04-14 | 1977-08-09 | Hoffmann-La Roche Inc. | Labelled peptides |
SU1063390A1 (en) * | 1982-01-07 | 1983-12-30 | Всесоюзный онкологический научный центр АМН СССР | Method of diagnosis of thyroid gland cancer |
Non-Patent Citations (1)
Title |
---|
J. Oehlke et al "ENHANCEDINCORPORATION OF NONHYDROLYZABLE TRITIUM GNRH AND TRF BY CATALYTIC EXCHANCE LABELING", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, 1987, V.XXIV, NO.12, P.1484-1491. McKelvy, Jeffrey F. ET AL "Rapid and quantitative procedure for the purification of picomole quantities of salt-free synthetic [3H-Pro] thyrotropin releasing hormone", Analytical Biochemistry, 1975, 64(2), 609-14 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2624439C1 (en) * | 2016-05-17 | 2017-07-04 | Федеральное государственное бюджетное учреждение науки Институт молекулярной генетики Российской академии наук | 5-oxo-pro-arg-pro labeled by tritium on all amino acid residues |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201171199A1 (en) | METHOD FOR CLEANING RECOMBINANT FSH | |
RU2513852C1 (en) | UNIFORMLY TRITIUM-LABELLED PYRO-Glu-His-Pro-NH2 | |
RU2368613C1 (en) | Uniformly tritium-labeled 4,4-difluoro-n-{(1s)-3-[3-(3-isopropyl-5-methyl-4h-1,2,4-triazol-4-yl)-8-azabicyclo[3,2,1]oct-8-yl]-1-phenylpropyl}cyclohexane carbodiimide | |
RU2491281C1 (en) | Uniformly tritiated 4-iodo-n-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]benzensuphonamide | |
Shevchenko et al. | Specific features of deuterium and tritium labeling of Pro-Gly-Pro-Leu and of physiologically active amino acids | |
RU2422436C1 (en) | 4-(2-aminoethyl)pyrocatechol uniformly labelled with deuterium or tritium using nanodiamond powder | |
CN104311651A (en) | Method for preparing fluorescent single-labeled cobra neurotoxin | |
RU2544016C1 (en) | UNIFORM DEUTERIUM- OR YTTRIUM-LABELLED His-Phe-Arg-Trp-Pro-Gly-Pro | |
RU2469023C1 (en) | 4-[2-(4-benzylpiperidin-1-yl)-hydroxypropyl] phenol uniformly labelled with tritium | |
JP2013164382A (en) | Additive agent of matrix for mass analysis | |
CN105218645A (en) | A kind of Caspofungin impurity C of high-purity high-yield 0preparation method | |
RU2291142C1 (en) | 2-AMINO-4-(β-HYDROXYETHYLAMINO)ANISOLE UNIFORMLY LABELED WITH TRITIUM | |
RU2398755C1 (en) | 5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol uniformly labelled with tritium | |
RU2624439C1 (en) | 5-oxo-pro-arg-pro labeled by tritium on all amino acid residues | |
RU2620190C2 (en) | Uniformized by dieterium and tritium 3-(1-methylpyrrolidine-2-yl) pyridine | |
RU2233285C1 (en) | Highly tritium labeled [3h]-rapamycin | |
RU2323224C1 (en) | Tritium uniformly labeled 3h-amphotericin b | |
RU2326889C1 (en) | α-HEDERIN UNIFORMLY MARKED WITH TRITIUM | |
RU2499786C1 (en) | UNIFORMLY LABELLED (3aS, 5S, 6R, 7aR, 7bS, 9aS, 10R, 12aS, 12bS)-10-[(2S, 3R, 4R, 5S)-3,4-DIHYDROXY-5,6-DIMETHYL-2-HEPTANYL]-5,6-DIHYDROXY-7a,9a-DIMETHYLHEXADECANE HYDRO-3H-BENZO [c]INDENO [5,4-e]OXEPIN-3-ONE TRIMER | |
RU2668982C1 (en) | Tritiated 3,7-bis(2,3-dihydro-1-benzofuran-5-ylcarbonyl)-1,5-dimethyl-3,7-diazabicyclo[3.3.1]nonan-9-one | |
RU2189971C1 (en) | Highly labeled with tritium | |
RU2318806C1 (en) | Tritium uniformly labeled [3h]-trans-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxo-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenic acid | |
RU2695074C1 (en) | Tritium-labeled 6,7-dimethoxy-4,4-dimethyl-1-(4-phenoxy-phenyl)-3n-isoquinoline | |
RU2248965C1 (en) | Tritium highly labeled [3h]-(s)-alpha-cyano-3-phenoxybenzyl-(1r)-(2',2'-dibromovinyl)-2,2-dimethyl cyclopropane carboxylate | |
CN108129538B (en) | Method for extracting antibacterial compound from scorpion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160212 |